As demonstrated by oxyntomodulin, a weak endogenous agonist for GLP-1 receptor and glucagon receptor, a strategy that simultaneously stimulates both GLP-1 and glucagon receptors can reduce food intake while increasing energy expenditure, synergistically enhancing weight loss [105-107]
Buyer Takeaway: The side-effect profile for a botanical adhesive patch is generally low-risk for most adult users - the main variable is interaction with prescription medications
While acknowledging the importance of T2D in fibrosis progression, the MAESTRO-NASH trial design imposed specific criteria for participants with diabetes, who comprised ~70% of the study population
GLP-1 medications are rightly celebrated for their effects on blood sugar and weight
Cold Sensitivity as a Metabolic Adaptation Signal Rather than a harmful side effect, increased cold sensitivity sometimes reflects your metabolism successfully adapting to lower caloric intake and improved energy efficiency
However, when paired with GLP-1 in dual agonists like tirzepatide, the combination works synergistically to suppress appetite and increase energy expenditure